Viridian Therapeutics, Inc. company logo
Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc. (VRDN) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$99.59M$3.23M-3.14%

Summary

Current Value
As of today, VRDN annual cash & cash equivalents is $99.59M, down -3.14% on
Historical Performance
VRDN annual cash & cash equivalents is up +135.45% over the past 3 years, and up +300.85% over the past 5 years
All-Time High Comparison
VRDN annual cash & cash equivalents is currently -35.98% below its historical high of $155.58M set on
3-Year Low Comparison
VRDN annual cash & cash equivalents is at its 3-year low
Sector Comparison
VRDN annual cash & cash equivalents is higher than 65.42% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRDN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$99.59M-3.1%+135.4%+300.9%+10000.0%
Quarterly Cash & Cash Equivalents$490.90M-34.8%+13.8%+1532.0%
Price$30.57+46.2%+11.3%+66.1%
Annual Current Assets$738.46M+51.8%+268.9%+2383.1%+10000.0%
Annual Total Liabilities$70.76M+46.2%+342.5%+192.1%
Annual Working Capital$690.59M+50.2%+270.2%+3430.8%+3247.8%
Annual Net Income-$208.56M+12.3%-162.6%-398.1%-3612.2%

Cash and Cash Equivalents Highs

VRDN Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$155.58MN/A-36.0%
5Y$155.58M-36.0%
All$155.58M-36.0%

Cash and Cash Equivalents Lows

VRDN Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$99.59Mat low
5Y$42.30M+135.4%
All$112.50K>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$99.59M-3.1%
$102.83M-33.9%
$155.58M+267.8%
$42.30M-7.8%
$45.90M+84.7%
$24.85M-23.8%
YearValueChange
$32.61M-31.3%
$47.44M+1,320.0%
$3.34M-69.2%
$10.83M+111.6%
$5.12M-

FAQ

  • What is the current annual cash & cash equivalents of VRDN?

    As of today, VRDN annual cash & cash equivalents is $99.59M

  • What is 1-year change in VRDN annual cash & cash equivalents?

    VRDN annual cash & cash equivalents is down -3.14% year-over-year

  • What is 3-year change in VRDN annual cash & cash equivalents?

    VRDN annual cash & cash equivalents is up +135.45% over the past 3 years

  • How far is VRDN annual cash & cash equivalents from its all-time high?

    VRDN annual cash & cash equivalents is currently -35.98% below its historical high of $155.58M set on December 31, 2022

  • How does VRDN annual cash & cash equivalents rank versus sector peers?

    VRDN annual cash & cash equivalents is higher than 65.42% of companies in Healthcare sector

  • When is VRDN next annual earnings release?

    The next annual earnings release for VRDN is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. VRDN Official Website www.viridiantherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590750/000159075025000020/0001590750-25-000020-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075025000004/0001590750-25-000004-index.htm
  4. VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
  5. VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn